Jonathan Schwartz

Company: Rocket Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Optimizing Muscle Targeting 2:00 pm

Evaluating the vectors and promoters currently used for muscular disorders Discussing the challenges and opportunities of current vector discovery approaches Which vectors are showing preclinical promise for the muscle? Is non-viral a viable option?Read more

day: Post-Conference Day

Targeting Cardiac Muscle with AAV: Past, Present & Future 1:30 pm

AAV9 cardiotropism: pre-clinical and clinical evidence AAV optimization: potential for unintended consequences Enhanced and selective cardiac transduction: potential future strategiesRead more

day: Post-Conference Day